Cargando…

Metabolic Reprogramming in Health and Disease

This editorial aims to summarize the six scientific papers that contributed to this Special Issue.

Detalles Bibliográficos
Autor principal:	Chiellini, Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215439/ https://www.ncbi.nlm.nih.gov/pubmed/32316318 http://dx.doi.org/10.3390/ijms21082768

Ejemplares similares

Understanding Amyloid Structures and Disease: A Continuing Challenge in Health Research
por: Chiellini, Grazia
Publicado: (2021)

Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3‐iodothyronamine
por: Selen Alpergin, Ebru S., et al.
Publicado: (2017)

Metabolic Reprogramming and Vulnerabilities in Cancer
por: Lyssiotis, Costas A., et al.
Publicado: (2019)

Editorial: Metabolic reprogramming and cancer progression
por: Yin, Qinan, et al.
Publicado: (2022)

Understanding metabolic reprogramming in tumor microenvironment
por: Shu, Shaokun, et al.
Publicado: (2022)

Editorial: Calcium Metabolism: Hormonal Crosstalk, Pathophysiology and Disease
por: Battafarano, Giulia, et al.
Publicado: (2022)

Metabolic reprogramming of myeloid-derived suppressive cells
por: Du, Hong, et al.
Publicado: (2017)

TLR8 reprograms human Treg metabolism and function
por: Liu, Xia, et al.
Publicado: (2019)

Poldip2 takes a central role in metabolic reprograming
por: Paredes, Felipe, et al.
Publicado: (2018)

Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming
por: Márquez, Javier, et al.
Publicado: (2021)

Circular RNA: The main regulator of energy metabolic reprogramming in cancer cells
por: Zhang, Liyi
Publicado: (2019)

Hungry for Chloride: Reprogramming Endothelial Cell Metabolism in Pulmonary Arterial Hypertension
por: Bousseau, Simon, et al.
Publicado: (2022)

3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
por: Rutigliano, Grazia, et al.
Publicado: (2020)

Update on 3-iodothyronamine and its neurological and metabolic actions
por: Zucchi, Riccardo, et al.
Publicado: (2014)

Corruptive Reprograming of Macrophages into Tumor-Associated Macrophages: The Transcriptional, Epigenetic and Metabolic Basis
por: Ahmad, Aamir
Publicado: (2023)

Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression
por: Assadi-Porter, Fariba M., et al.
Publicado: (2018)

Stem Cells and Nuclear Reprogramming
por: Du, Fuliang, et al.
Publicado: (2011)

Tilting the Scales: Sirtuin 1 Favors Proinflammatory Macrophage Response Via Inflammasome Signaling and Metabolic Reprogramming
por: Kennedy, Lindsey
Publicado: (2022)

New Developments in Nutraceuticals and Functional Food Products: Microorganisms as Alternative Sources of Nutritive and Beneficial Components
por: Chiellini, Carolina, et al.
Publicado: (2023)

Glucose metabolic reprogramming in autoimmune diseases
por: Jeong, Hoim, et al.
Publicado: (2023)

Epigenetic Control of Reprogramming and Cellular Differentiation
por: Latella, Lucia, et al.
Publicado: (2012)

IF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer
por: Sánchez-Aragó, María, et al.
Publicado: (2012)

Innate Immune Reprogramming in Chronic Obstructive Pulmonary Disease: New Mechanisms for Old Questions
por: Kim, Richard Y., et al.
Publicado: (2023)

Why Cell Reprogramming is Functionally Linked to Aging?
por: Zhao, Jian, et al.
Publicado: (2011)

Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer’s Disease?
por: Saponaro, Federica, et al.
Publicado: (2020)

Metabolic Reprogramming After Left Ventricular Assist Device: Remodeling Without Recovery of Cardiac Energetics
por: Rame, J. Eduardo, et al.
Publicado: (2016)

mRNA Metabolism in Health and Disease
por: Romão, Luísa
Publicado: (2022)

Metabolic reprogramming heterogeneity in chronic kidney disease
por: Miguel, Verónica, et al.
Publicado: (2023)

Metabolic Reprogramming in Glioma
por: Strickland, Marie, et al.
Publicado: (2017)

Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders
por: Saponaro, Federica, et al.
Publicado: (2020)

Restoring Epigenetic Reprogramming with Diet and Exercise to Improve Health-Related Metabolic Diseases
por: Abraham, Merlin Jesso, et al.
Publicado: (2023)

Epigenetic reprogramming in the mammalian germline
por: Hsu, Fei-Man, et al.
Publicado: (2015)

Single short reprogramming early in life increases healthspan
por: Milhavet, Ollivier, et al.
Publicado: (2022)

Amino Acid Nutrition and Metabolism in Health and Disease
por: Rose, Adam J.
Publicado: (2019)

Immune cell metabolism and metabolic reprogramming
por: Hu, Chenchen, et al.
Publicado: (2022)

An Unknown Piece of Early Work of Nuclear Reprogramming in Fish Eggs
por: Deng, Chuxia, et al.
Publicado: (2010)

‘mi’-nimal interference: Somatic cell reprogramming in cancer and therapy
por: Doran, Graeme
Publicado: (2009)

Macrophage metabolic reprogramming during chronic lung disease
por: Ogger, Patricia P., et al.
Publicado: (2020)

Inflexibility of AMPK-mediated metabolic reprogramming in mitochondrial disease
por: Lin, Dar-Shong, et al.
Publicado: (2017)

Metabolic reprogramming of macrophages and its involvement in inflammatory diseases
por: Guo, Chunyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a9no2etsln1htdv1rqk8vjt1lm